Find NCI Program Director Contacts for the following Divisions, Centers, and Offices
NCI Divisions
- Division of Cancer Biology (DCB)
- Division of Cancer Control and Population Sciences (DCCPS)
- Division of Prevention (DCP)
- Division of Cancer Treatment and Diagnosis (DCTD)
NCI Centers, Offices, and Programs
- Center for Cancer Training (CCT)
- Center for Global Health (CGH)
- Center to Reduce Cancer Health Disparities (CRCHD)
- Center for Strategic Scientific Initiatives (CSSI)
- Innovative Molecular Analysis Technologies Program (IMAT)
- Office of HIV and AIDS Malignancies (OHAM)
- Provocative Questions Program (PQ)
- Small Business & Small Business Technology Transfer (SBIR/STTR)
NCI Divisions
Find NCI Staff and Program Director contacts for the following NCI DivisionsDivision of Cancer Biology (DCB)
DCB supports and coordinates research projects in basic cancer biology at universities, hospitals, research foundations, and businesses across the United States and abroad.
DCB Staff Directory
Dr. Barbara Spalholz
301-276-6230
spalholb@mail.nih.gov
Cancer Etiology
Dr. Donald Blair
240-276-6190
blaird@mail.nih.gov
Cancer Immunology and Hematology
Dr. R. Allan Mufson
240-276-6200
mufsona@mail.nih.gov
DNA and Chromosome Aberrations
Dr. Judy Mietz
240-276-6250
mietzj@mail.nih.gov
Structural Biology and Molecular Applications
Dr. Jennifer Couch
240-276-6210
couchj@mail.nih.gov
Tumor Biology and Metastasis
Dr. Suresh Mohla
240-276-6220
mohlas@mail.nih.gov
DCB Programs
Mouse Models of Human Cancers Consortium
Dr. Cheryl Marks
240-276-6180
marksc@mail.nih.gov
Integrative Cancer Biology Program
Dr. Daniel Gallahan
240-276-6180
gallahad@mail.nih.gov
Tumor Microenvironment Network
Dr. Suresh Mohla
240-276-6220
mohlas@mail.nih.gov
Division of Cancer Control & Population Sciences (DCCPS)
DCCPS supports a comprehensive program of genetic, epidemiologic, behavioral, social, and surveillance cancer research.
DCCPS Staff Directory
Dr. Steven Taplin
240-276-6947
taplins@mail.nih.gov
Basic Biobehavioral and Psychological Sciences
Dr. Paige McDonald
240-276-6899
mcdonalp@mail.nih.gov
Cancer Statistics
Dr. Kathleen Cronin
240-276-6836
cronink@mail.nih.gov
Data Modeling
Dr. Angela Mariotto
240-276-6698
Angela_mariotto@nih.gov
Cancer Survivorship
Dr. Julia Rowland
240-276-6827
rowlandj@mail.nih.gov
Clinical and Translational Epidemiology
Dr. Andrew Freedman
240-276-6697
freedmaa@mail.nih.gov
Implementation Science
Dr. Russell Glasgow
240-276-6925
cvinson@mail.nih.gov
Health Communication and Informatics
Dr. Bradford W. Hesse
240-276-6721
hesseb@mail.nih.gov
Health Behaviors
Dr. Linda Nebeling
240-276-6855
nebelinl@mail.nih.gov
Health Services and Economics Research
Dr. Ann Geiger
240-276-6995
geigeram@mail.nih.gov
Host Susceptibility Research
Dr. Elizabeth Gillanders
240-276-6764
lgilland@mail.nih.gov
Methods and Technologies Research
Dr. Mukesh Verma
240-276-6889
vermam@mail.nih.gov
Modified Risk Factors
Dr. Britt Reid
240-276-6725
reidbr@mail.nih.gov
Outcomes Research
Dr. Steven B. Clauser
240-276-6948
clausers@mail.nih.gov
Risk Factor Monitoring and Methods
Dr. Susan M. Krebs-Smith
240-276-6949
krebssms@mail.nih.gov
Statistical Methodology and Applications
Dr. Eric J. "Rocky" Feuer
240-276-6772
feuerr@exchange.nih.gov
Tobacco Control Research
Dr. Michele Bloch
240-276-6878
blochm@mail.nih.gov
Surveillance Systems
Dr. Zaria Tatalovich
240-276-6976
tatalovichzp@mail.nih.gov
Division of Cancer Prevention (DCP)
DCP supports research to determine and reduce a person’s risk of developing cancer, as well as research to develop and evaluate cancer screening procedures.
DCP Staff Directory
Dr. Philip Prorok
301-496-7709
prorokp@mail.nih.gov
Breast and Gynecologic Cancer
Dr. Terri Cornelison
301-402-3963
cornelit@mail.nih.gov
Cancer Biomarkers
Dr. Sudhir Srivastava
301-496-3983
srivasta@mail.nih.gov
Chemopreventive Agent Development
Dr. Vernon Steele
301-594-0420
steelev@mail.nih.gov
Community Oncology & Prevention Trials
Dr. Lori Minasian
301-594-7868
minasilo@mail.nih.gov
Dr. Christine Berg
301-496-1071
bergc@mail.nih.gov
Gastrointestinal and Other Cancers
Dr. Asad Umar
301-594-7671
umara@mail.nih.gov
Lung and Upper Aerodigestive Cancer
Dr. Eva Szabo
301-435-2456
szaboe@mail.nih.gov
Nutritional Science
Dr. John Milner
301-496-0118
milnerj@mail.nih.gov
Prostate and Urologic Cancer
Dr. Howard Parnes
301-402-3606
parnesh@nih.gov
Division of Cancer Treatment and Diagnosis (DCTD)
DCTD supports the translation of promising research areas into improved diagnostic and therapeutic interventions for cancer patients.
DCTD Staff Directory
Cancer Diagnosis Program
Dr. Barbara Conley
240-276-5680
barbara.conley@nih.gov
Cancer Imaging Program
Dr. Paula Jacobs
240-276-5950
jacobsp@mail.nih.gov
Cancer Therapy Evaluation Program
Dr. Jeffrey Abrams
240-276-6515
abramsj@ctep.nci.nih.gov
Developmental Therapeutics Program
Dr. Jerry Collins
240-276-6520
collinsje@maol.nih.gov
Complementary and Alternative Medicine
Dr. Jeffrey D. White
240-276-6595
jeffreyw@mail.nih.gov
Radiation Research Program
Dr. C. Norman Coleman
240-276-5690
coleman@mail.nih.gov
Translational Research Program (including SPOREs)
Dr. Toby Hecht
240-276-5683
hechtt@mail.nih.gov
NCI Centers, Offices, and Programs
Find NCI Program Director contacts for the following NCI Centers, Offices, and Selected Programs.
Center for Cancer Training (CCT)
CCT provides funding to support training and career development for cancer researchers working at institutions nationwide and also manages intramural training programs offered at NCI laboratories and offices.
CCT Staff Directory
Dr. Ming Lei
240-276-5630
leim@mail.nih.gov
Center for Global Health (CGH)
CGH facilitates global collaboration by leveraging research resources with U.S. government agencies, foreign governments, non-government organizations, and pharmaceutical and biotechnology companies.
CGH web site
Dr. Edward Trimble
240-276-5796
trimblet@mail.nih.gov
Center to Reduce Cancer Health Disparities (CRCHD)
CRCHD supports the reduction of cancer health disparities in diverse populations through research, training, and partnerships.
CRCHD Staff Directory
Center for Strategic Scientific Initiatives (CSSI) CSSI provides support for innovative programs that includes clinical proteomics, cancer genomics, nanotechnology, and physical sciences cancer research.
CSSI Staff Directory
The Center for Cancer Genomics (CCG) manges TCGA and OCG
OCG supports programs that will enhance our understanding of the molecular mechanisms of cancer.
Office of Cancer Clinical Proteomics
OCCPR supports the development of technologies and reagents that will advance our understanding of protein biology in cancer
Dr. Henry Rodriguez
301-451-8883
rodriguezh@mail.nih.gov
Office of Physical Sciences-Oncology
OPSO supports the establishment of scientific teams and individual scientists from the fields of physics, mathematics, chemistry, and engineering to develop novel approaches for cancer research.
Office of Nanotechnology Research
OCNR directs the NCI Alliance for Nanotechnology in Cancer program that supports the application of nanotechnology to all aspects of cancer research.
Dr. Piotr Grodzinski
301-594-6345
grodzinp@mail.nih.gov
Innovative Molecular Analysis Technologies Program (IMAT)
IMAT is a NCI initiative that supports the development of novel technologies that support clinical, laboratory, and epidemiology cancer research.
IMAT Staff Directory
Dr. Tony Dickherber
301-547-9980
anthony.dickherber@nih.gov
Office of HIV and AIDS Malignancies (OHAM)
OHAM coordinates HIV/AIDS research throughout the NCI, including programs in AIDS-related cancer.
OHAM Staff Directory
Dr. Robert Yarchoan
301-496-0328
yarchoan@helix.nih.gov
Provocative Questions Program (PQ)
PQ is a NCI initiative that intends to assemble a list of important questions, or problems that are paradoxes in cancer research that will stimulate research communities to use laboratory, clinical, and population sciences in new, effective, and imaginative ways.
PQ web site
Dr. Emily Greenspan
301-451-0943
emily.greenspan@mail.nih.gov
Small Business & Small Business Technology Transfer (SBIR/STTR)
SBIR and STTR programs seek to increase small business and private sector participation to develop and commercialize novel technologies to prevent, diagnose, and treat cancer.
SBIR/STTR Staff Directory
Michael Weingarten
240-276-5238
weingartenm@mail.nih.gov
Back to Top